FDA Product Code QOF: Multi-target Respiratory Specimen Nucleic Acid Test Including Sars-cov-2 And Other Microbial Agents
FDA product code QOF covers multi-target respiratory specimen nucleic acid tests.
These multiplex molecular assays simultaneously detect and identify multiple respiratory pathogens — including influenza A/B, RSV, SARS-CoV-2, and others — from a single patient sample. They provide faster and more comprehensive results than single-target tests, enabling rapid differentiation of respiratory illnesses.
QOF devices are Class II medical devices, regulated under 21 CFR 866.3981 and reviewed by the FDA Microbiology panel.
Leading manufacturers include Biofire Diagnostics, LLC, Roche Molecular Systems, Inc. and Cepheid.
31
Total
30
Cleared
180d
Avg days
2021
Since
31 devices
Cleared
Jul 27, 2023
cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System
Roche Molecular Systems, Inc.
Microbiology
238d
Cleared
May 16, 2023
Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
Hologic, Inc.
Microbiology
249d
Cleared
Apr 13, 2023
BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
Biofire Diagnostics, LLC
Microbiology
29d
Cleared
Mar 17, 2023
Simplexa COVID-19 & Flu A/B Direct
Diasorin Molecular, LLC
Microbiology
350d
Not Cleared
Mar 17, 2021
BioFire Respiratory Panel 2.1 (RP2.1)
Biofire Diagnostics, LLC
Microbiology
302d